{"id":"W2763004155","doi":"10.1016/j.ejca.2017.08.032","title":"Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma","year":2017,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; Health Sciences Centre; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Alcohol and Drug Abuse Institute, University of Washington; Merck","keywords":"Ipilimumab; Pembrolizumab; Medicine; Oncology; Internal medicine; Melanoma; Immunotherapy; Cancer; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003489383,0.001644787,0.002673287,0.0003661453,0.0004116212,0.001051188,0.0008401541,0.001919714,0.004961242],"category_scores_gemma":[0.003121462,0.000807651,0.002358333,0.0004087776,0.001002474,0.001304595,0.0007309504,0.003253422,0.000677161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007058542,"about_ca_system_score_gemma":0.0009542266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00041581,"about_ca_topic_score_gemma":0.0009653055,"domain_scores_codex":[0.9980843,0.001264995,0.0001360771,0.0002252143,0.0001350183,0.0001543394],"domain_scores_gemma":[0.9979443,0.000488082,0.0007212019,0.0001517085,0.0001005598,0.0005941729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9822041,0.004755105,0.001664853,0.0004092497,0.0009131834,0.0000323336,0.00004456563,0.0003045052,0.001987129,0.00003624017,0.0002506085,0.007398239],"study_design_scores_gemma":[0.8124769,0.1774735,0.007576744,0.00003504728,0.000831394,0.0000731274,0.00002925633,0.0003629916,0.0004805076,0.00007309631,0.0005688643,0.00001861363],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938891,0.002628841,0.0002818282,0.0002503917,0.0001942213,0.00145271,0.0006284112,0.0000289338,0.0006454841],"genre_scores_gemma":[0.993427,0.001234909,0.0006920154,0.0004255286,0.0002710218,0.002172847,0.0008091356,0.00000727035,0.0009601706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004961242,"threshold_uncertainty_score":0.0184539,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01614722972116736,"score_gpt":0.2909443206967434,"score_spread":0.274797090975576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}